PEPTICHEMIO, VINCRISTINE AND PREDNISONE VERSUS MELPHALAN AND PREDNISONE AS INDUCTION THERAPY IN MULTIPLE-MYELOMA

被引：14
|
作者：
RICCARDI, A
MERLINI, G
MONTECUCCO, C
DANOVA, M
UCCI, G
CASSANO, E
ASCARI, E
机构：
[1] CARATTERE SCI POLICLIN S MATTEO, IST RICOVERO & CURA, I-27100 PAVIA, ITALY
[2] UNIV PAVIA, DIPARTIMENTO MED INTERNA & TERAPIA MED, I-27100 PAVIA, ITALY
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 07期
关键词：
D O I：
10.1016/0277-5379(86)90364-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：787 / 791
页数：5
相关论文
共 50 条
  • [31] COMBINATION CHEMOTHERAPY WITH VINCRISTINE, MELPHALAN, CCNU, CYCLOPHOSPHAMIDE AND PREDNISONE FOR MYELOMA
    LELOET, X
    MONCONDUIT, M
    MENARD, JF
    DESHAYES, P
    GROBOIS, B
    TANGUY, A
    PREVOST, E
    PIGUET, H
    REVUE DU RHUMATISME, 1984, 51 (05): : 263 - 267
  • [32] Bortezomib plus Melphalan and Prednisone for Multiple Myeloma
    Avvisati, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (24): : 2613 - 2613
  • [33] Melphalan plus Prednisone Versus Melphalan plus Prednisone plus Thalidomide in Induction Therapy for Multiple Myeloma in Elderly Patients: Final Analysis of the Dutch Cooperative Group HOVON 49 Study
    Wijermans, P.
    Schaafsma, M.
    van Norden, Y.
    Ammerlaan, R.
    Wittebol, S.
    Sinnige, H.
    Zweegman, Sonja
    Kooi, M. van Marwijk
    Van der Griend, R.
    Lokhorst, H.
    Sonneveld, P.
    BLOOD, 2008, 112 (11) : 241 - 242
  • [34] POLYCHEMOTHERAPY OF MULTIPLE-MYELOMA USING VINCRISTINE, CYCLOPHOSPHAMIDE, CCNU, MELPHALAN, PREDNISONE AND COMPARISON OF 2 MAINTENANCE TREATMENTS, VM26-CYCLOPHOSPHAMIDE VERSUS LEVAMISOLE
    MONCONDUIT, M
    LELOET, X
    MENARD, JF
    GROSBOIS, B
    TILLY, H
    DARAGON, A
    TANGUY, A
    PIGUET, H
    DESHAYES, P
    BULLETIN DU CANCER, 1986, 73 (04) : 441 - 441
  • [35] Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients
    Palumbo, A.
    Bringhen, S.
    Caravita, T.
    Falcone, A.
    Callea, V.
    Cangialosi, C.
    Grasso, M.
    Galli, M.
    Rossini, F.
    Catalano, L.
    Montanaro, M.
    De Stefano, V.
    Magarotto, V.
    Avonto, I.
    Musto, P.
    Liberati, A. M.
    Cavo, M.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 147 - 147
  • [36] PEPTICHEMIO IN MULTIPLE-MYELOMA
    MARMONT, A
    HAEMATOLOGICA, 1981, 66 (06) : 879 - 879
  • [37] PROGNOSTIC FACTORS AND SURVIVAL IN MULTIPLE-MYELOMA - ANALYSIS OF 91 CASES TREATED BY MELPHALAN AND PREDNISONE
    GOBBI, M
    CAVO, M
    SAVELLI, G
    BACCARANI, M
    TURA, S
    HAEMATOLOGICA, 1980, 65 (04) : 437 - 445
  • [38] MELPHALAN-PREDNISONE-CYCLOPHOSPHAMIDE (MP+C) VS MP FOR MULTIPLE-MYELOMA
    GIBBS, G
    KIANG, DT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 373 - 373
  • [39] CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE AND VINDESINE COMBINATION CHEMOTHERAPY IN MELPHALAN-RESISTANT MULTIPLE-MYELOMA
    VANDOBBENBURGH, OA
    HOUWEN, B
    PIERSMA, H
    MARRINK, J
    OCKHUIZEN, T
    HALIE, MR
    NIEWEG, HO
    NETHERLANDS JOURNAL OF MEDICINE, 1984, 27 (02): : 25 - 30
  • [40] MONOCHEMOTHERAPY (MELPHALAN + PREDNISONE) VERSO POLYCHEMOTHERAPY ALTERNATA (VMCP/VBAP) NEL MULTIPLE-MYELOMA
    MUSTO, P
    BAVARO, P
    BODENIZZA, C
    MELILLO, L
    CAROTENUTO, M
    TUMORI, 1986, 72 (06) : 720 - 720
12345